Back to search

Article

Engineered hematopoietic stem cells give rise to therapeutic antibody secreting B cells

2026-04-06

Abstract excerpt

<title>Abstract</title> <p>Monoclonal antibodies represent half of the top ten selling drugs. Their proven efficacy, however, generally requires repeated administration for prolonged periods of time. In contrast, cell-based therapies offer a different set of pharmacokinetics and pharmacodynamics than traditional medicines, including the potential to have lifetime durability after a single infusion. Here, we descr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
020d4d83-e589-5bfa-86fc-9f794653a6b4
DOI
10.21203/rs.3.rs-9269825/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Engineered hematopoietic stem cells give rise to therapeutic antibody secreting B cellsDOI 10.21203/rs.3.rs-9269825/v1
Select a neighboring publication to make it the new centre.